Blue Horseshoe Stocks: PBR & GEIG Updates, Extended Watchlist

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

To start off a new trading week, we’re going to follow up on Friday’s mention of PBR Calls, which ended up with a fantastic performance by all accounts. If you recall, in Friday Morning’s Report, we indicated that we were “interested in the potential of the $16.50 and $17.00 Weekly Calls” for intraday flip opportunities.

As you can see on the Level 2 Snapshot below, the $16.50 Calls traded in a range from .25-.63, an intraday move 152% The $17 Calls did considerably better, screaming up from a low of .04 and running as high as .23; good for enormous gains of up to 475%

To begin the week, we’ll remain interested in the $16.50 and $17 Weekly Calls, provided PBR can hold support at Friday’s swing low of 16.66


GEI Global Energy Corp. GEIG

In our most recent GEIG alert (Wednesday), we stated that we needed to “keep a sharp eye out for a bottom… as it gets itself in gear for the next leg-up.”

The stock was searching for a base of support from which to launch its next upswing, and found it at .007 shortly prior to the close on Thursday. Friday’s session would prove most advantageous, as the stock sailed back upward to as high as .02, marking a 185% spike off of that bottom.

That was the second golden opportunity presented to us by GEIG in as many weeks; remember, we called it the week before last as well, and were rewarded with a single-session move of over 700% with traders easily being able to play the stock for gains in the 400% range. The high on that run was .08, so its quite possible to see GEIG make further strides from current levels.



Side Note:

We’re still monitoring FB Calls as we pointed out at the beginning of last week. We’ll be looking to capitalize on the volatility that comes with rising anticipation of earnings, due for release on Wednesday. It won’t be the first time we’ve used this tactic, and it isn’t likely to be the last.

In the midst of earnings season, we’re focused on using the trends to our advantage in making some potentially big options trades, not just with FB, but many others as well.


Extended Watchlist:
PLUG, NQ, EXTR, CLWT, CTIC, ATRX, NLST, KNDI

Blue Horseshoe Stocks: PSID, KNDI, PBR & Extended Watchlist

PositiveID Corp. PSID

The first thing we’d like to do this morning is go over how well PSID performed yesterday following our pre-market alert. Our timing proved to be spot-on in calling the bottom on this play, and after putting it on high alert in our report, we were rewarded with a couple of chances to gain over the course of the session.

The stock ran hard out of the starting gate, with trading opening up at .043 and rapidly reaching the day’s high at .064, a spike of 48% That was followed by a pullback to .049 where we got another upswing, this time to .058, a modest yet respectable intraday move of 18%

Those two significant swings combined for cumulative total gains of 66% on the day, and the stock managed to close at .057, holding on to much of the day’s forward progress. This all occurred on roughly 6x PSID’s 3-month average volume.

Congrats to anyone who was able to make PSID work for them, and be sure to stay tuned, as a performance like that could lead to a strong finish to the week.


Kandi Technologies Group, Inc. KNDI

This is a stock that we’ve been tracking for over a year now, as a quick look at KNDI’s archive on our blog will reveal. Our most recent tag of this stock came via Monday morning’s extended watchlist, and over the course of the week, it has yielded quite a nice move; We saw a low of 15.76 on Monday, and by yesterday’s session we observed a high of 20.96, an intraweek gain of 33%

Those who may have picked up on this play following our next most recent alert of this play (June 12th ) could have caught a low of 12.30. Yesterday’s high marked a 70% move up from that level.


Petroleo Brasiliero S.A. (Petrobras) PBR

Our regulars are aware of how tenaciously we’ve covered PBR this year. On March 21st we added it to our watchlist as it was coming off of 10-year lows. Our observed low that day was 11.25, and the stock never looked back. We’ve traded primarily in the options chain of PBR and have made percentage gains in the thousands over the course of several months, but even the overall action on the stock itself has been impressive.

Yesterday’s session set a new high of 16.43 and in premarket trading today that has been pushed to more than $17, from the low we saw this spring, that’s an overall move of over 50% on the chart.

However, the swing action on this play over the past few months has been terrific, as we’ve pointed out on the following chart. As you can see, after our initial alert, there have been no less than three major swings. The current positioning breaks PBR out of the channel we illustrate below, signaling potential for further moves to the upside.

As far as the options chain is concerned, we’ll be looking for a pullback from profit taking on this major spike, and after that, we’re interested in the potential of the $16.50 and $17.00 Weekly Calls for an intraday flip opportunity today.


Extended Watchlist:
ICLD, JDST, OMEX, ACRX, EVI

Blue Horseshoe Stocks: Special Report on PSID

Positive ID Corp. PSID

This morning we are going to revisit a play that brought us tremendous success earlier this year. Back in February, we tracked PSID over an impressive range from .0572 to .125, giving us the chance at close to 120% in gains. More recently, the stock has consolidated down to find support at .04, and we think the chart is beginning to look very ripe for a bounce. We’ll get to that in a minute, but first, for those of our readers that may not yet have been members this past winter, we’ll take a look at what Positive ID Corp actually does.

Essentially, PSID develops microfluidic systems for automated biological assays with applications ranging from homeland security and defense, to point-of-care biological sample analysis. In addition, each of these systems is being evaluated by some very high-profile entities:

M-BAND – PSID’s Microluidic Bio-Agent Autonomous Networked Detector is a fully-integrated bioaerosol monitor which performs multiplex assays using cell lysis and nucleic acid purification. It operates autonomously for up to 30 Days, providing continuous analysis of air samples and screening for bacteria, viruses, and toxins.

Firefly Dx – For point-of-care diagnosis, the FireFly Dx system is a portable handheld device capable of sample lysis, purification, PCR analysis and more, allowing for efficient field testing.

In March, PSID struck a contract with a large commercial partner to support a U.S. Department of Defense contract. The program will test and evaluate the M-BAND bio-threat detector for use by the U.S. military. PSID has announced that it expects to generate a sum of $841K in revenues from this contract in 2014.

More recently, in May, it was announced that PSID had signed a ‘Space Act Agreement’ with NASA’s Ames Research Center, under the terms of which NASA will assess Positive ID’s Firefly technology for potential ground and space applications, which we think is really cool!

There have also been a few other PR’s released over roughly the past month that warrant our attention, the links to which you can find below the following chart commentary:

The RSI is looking oversold, the MACD is gearing up to flip to the bullish side, and the chart is looking like it has tremendous potential as a bottom-play, with support having held off of a previously proven level at .04 for the past three sessions.

Due to this current positioning of the PSID Chart, and the nature of this morning’s press release, we are placing the stock on high alert today, and will want to pay extra attention to this play in coming sessions.

You can also take a look at the PSID chart via this quick video presentation:

LINKS TO RECENT PRESS:

DON’T MISS TODAY’S EXCITING NEWS:

PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract

Order Increases the Value of Existing Department of Defense Contract; PositiveID Increases Revenue/Backlog Estimate to $3.5 Million; Reiterates Revenue Guidance of $4-10 Million Through the End of 2015 >> CLICK FOR PR

More Information @ www.positiveidcorp.com